These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25694022)

  • 1. The future of industrial bioprocessing: batch or continuous?
    Croughan MS; Konstantinov KB; Cooney C
    Biotechnol Bioeng; 2015 Apr; 112(4):648-51. PubMed ID: 25694022
    [No Abstract]   [Full Text] [Related]  

  • 2. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous downstream processing of biopharmaceuticals.
    Jungbauer A
    Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precipitation as an Enabling Technology for the Intensification of Biopharmaceutical Manufacture.
    Martinez M; Spitali M; Norrant EL; Bracewell DG
    Trends Biotechnol; 2019 Mar; 37(3):237-241. PubMed ID: 30316558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New areas of plant-made pharmaceuticals.
    Hassan SW; Waheed MT; Lössl AG
    Expert Rev Vaccines; 2011 Feb; 10(2):151-3. PubMed ID: 21332263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of difficult-to-remove host cell protein impurities during extended Chinese hamster ovary cell culture and their impact on continuous bioprocessing.
    Valente KN; Lenhoff AM; Lee KH
    Biotechnol Bioeng; 2015 Jun; 112(6):1232-42. PubMed ID: 25502542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous downstream processing for high value biological products: A Review.
    Zydney AL
    Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in industrial biopharmaceutical batch process monitoring: Machine-learning methods for small data problems.
    Tulsyan A; Garvin C; Ündey C
    Biotechnol Bioeng; 2018 Aug; 115(8):1915-1924. PubMed ID: 29624632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state of the art in continuous bioprocessing.
    Schofield M
    Biotechnol Lett; 2018 Oct; 40(9-10):1303-1309. PubMed ID: 30006662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recovery of highly purified biopharmaceuticals from perfusion cell culture bioreactors.
    Prior CP; Doyle KR; Duffy SA; Hope JA; Moellering BJ; Prior GM; Scott RW; Tolbert WR
    J Parenter Sci Technol; 1989; 43(1):15-23. PubMed ID: 2926601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarification technologies for monoclonal antibody manufacturing processes: Current state and future perspectives.
    Singh N; Arunkumar A; Chollangi S; Tan ZG; Borys M; Li ZJ
    Biotechnol Bioeng; 2016 Apr; 113(4):698-716. PubMed ID: 26302443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells.
    Rodrigues AF; Carrondo MJ; Alves PM; Coroadinha AS
    Trends Biotechnol; 2014 Dec; 32(12):602-7. PubMed ID: 25450042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational and systematic protein purification process development: the next generation.
    Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M
    Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viruses and assuring viral safety.
    Robertson JS
    Dev Biol (Basel); 2003; 113():73-7. PubMed ID: 14620855
    [No Abstract]   [Full Text] [Related]  

  • 17. Untapped Resources: Biotechnological Potential of Peptides and Secondary Metabolites in Archaea.
    Charlesworth JC; Burns BP
    Archaea; 2015; 2015():282035. PubMed ID: 26504428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale processing of macromolecules.
    Fulton SP
    Curr Opin Biotechnol; 1994 Feb; 5(2):201-5. PubMed ID: 7764801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in in-situ product recovery (ISPR) in whole cell biotechnology during the last decade.
    Van Hecke W; Kaur G; De Wever H
    Biotechnol Adv; 2014 Nov; 32(7):1245-1255. PubMed ID: 25072605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host cell proteins in biotechnology-derived products: A risk assessment framework.
    de Zafra CL; Quarmby V; Francissen K; Vanderlaan M; Zhu-Shimoni J
    Biotechnol Bioeng; 2015 Nov; 112(11):2284-91. PubMed ID: 26010760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.